CMC analytical considerations and challenges for oligonucleotides and oligonucleotide-conjugates
30 Apr 2026
CMC & Process Development
- Analytical techniques, considerations and gaps supporting oligonucleotide and oligonucleotide-conjugate drug development
- Method development, validation & transfer challenges
- Impurity identification and characterization for complex modalities
